Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0002094682-25-000002
Filing Date
2025-10-31
Accepted
2025-10-31 14:13:43
Documents
19

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 33207
2 JOINT FILING AGREEMENT jointagnames.pdf EX-1 117474
3 POA BUTTERWORTH poabutterworth.pdf EX-2 115178
4 POA R JONES poarjones.pdf EX-3 115523
5 POA E JONES poaejones.pdf EX-4 115504
6 POA DOWNING poadowning.pdf EX-5 115151
7 POA KOTEY poakotey.pdf EX-7 115772
8 POA COLE poacole.pdf EX-8 115152
9 POA CHAUDREY poachaudrey.pdf EX-9 115162
10 POA BABB poababb.pdf EX-10 115148
11 POA CRAIG poacraig.pdf EX-11 115154
12 POA NICHOLLS poanicholls.pdf EX-12 115511
13 POA WARE poaware.pdf EX-13 115150
14 POA TURNER poaturner.pdf EX-14 115155
15 POA ROBBINS poarobbins.pdf EX-15 115194
16 POA STEAD poastead.pdf EX-16 115528
17 POA HENNESSY poahennessy.pdf EX-17 115166
18 POA ARNOLD poaarnold.pdf EX-18 115149
19 POA DOUGLAS poadouglas.pdf EX-19 115180
  Complete submission text file 0002094682-25-000002.txt   2899151
Mailing Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301
Business Address 501 E LAS OLAS BLVD SUITE 300 FORT LAUDERDALE FL 33301 (346) 355-4099
Alaunos Therapeutics, Inc. (Subject) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-79364 | Film No.: 251439872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6 THE PENINSULA PANORAMA ROAD POOLE United Kingdom BH13 7RS
Business Address
Price Adrian (Filed by) CIK: 0002094682 (see all company filings)

Type: SCHEDULE 13D/A